154 related articles for article (PubMed ID: 3770314)
1. Apolipoprotein E polymorphism and hyperlipemia in type II diabetics.
Eto M; Watanabe K; Iwashima Y; Morikawa A; Oshima E; Sekiguchi M; Ishii K
Diabetes; 1986 Dec; 35(12):1374-82. PubMed ID: 3770314
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E polymorphism in non-insulin-dependent diabetics of Mumbai, India and its effect on plasma lipids and lipoproteins.
Inamdar PA; Kelkar SM; Devasagayam TP; Bapat MM
Diabetes Res Clin Pract; 2000 Mar; 47(3):217-23. PubMed ID: 10741571
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
Horita K; Eto M; Makino I
Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
[TBL] [Abstract][Full Text] [Related]
4. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.
Hazzard WR; Warnick GR; Utermann G; Albers JJ
Metabolism; 1981 Jan; 30(1):79-88. PubMed ID: 7464557
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW
J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism.
Cohn JS; Tremblay M; Boulet L; Jacques H; Davignon J; Roy M; Bernier L
Atherosclerosis; 2003 Jul; 169(1):63-70. PubMed ID: 12860251
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
Minnich A; Weisgraber KH; Newhouse Y; Dong LM; Fortin LJ; Tremblay M; Davignon J
J Lipid Res; 1995 Jan; 36(1):57-66. PubMed ID: 7706948
[TBL] [Abstract][Full Text] [Related]
8. Electrophoretic analysis of oxidative modification of apolipoprotein E in very low density lipoprotein from fresh human plasma.
Kashiwagi S; Nakamura K; Arai H; Yamashita H; Ito H
Electrophoresis; 1999 Jun; 20(7):1418-24. PubMed ID: 10424464
[TBL] [Abstract][Full Text] [Related]
9. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of apolipoprotein E, lipoprotein(a), and other lipoproteins in children with type I diabetes.
Salzer B; Stavljenić A; Jürgens G; Dumić M; Radica A
Clin Chem; 1993 Jul; 39(7):1427-32. PubMed ID: 8330401
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.
Weisgraber KH
J Lipid Res; 1990 Aug; 31(8):1503-11. PubMed ID: 2280190
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.
Ordovas JM; Litwack-Klein L; Wilson PW; Schaefer MM; Schaefer EJ
J Lipid Res; 1987 Apr; 28(4):371-80. PubMed ID: 3585172
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E isoforms and lipoprotein metabolism.
Phillips MC
IUBMB Life; 2014 Sep; 66(9):616-23. PubMed ID: 25328986
[TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
[TBL] [Abstract][Full Text] [Related]
15. ApoE-2/E-3 ratio of very low density lipoprotein in diabetes mellitus.
Sano R; Abe R; Oikawa S; Fujii Y; Toyota T
Tohoku J Exp Med; 1985 Jun; 146(2):131-6. PubMed ID: 4024089
[TBL] [Abstract][Full Text] [Related]
16. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg RE; Zech LA; Schaefer EJ; Stark D; Wilson D; Brewer HB
J Clin Invest; 1986 Sep; 78(3):815-21. PubMed ID: 3745440
[TBL] [Abstract][Full Text] [Related]
17. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
Tsukamoto K; Maugeais C; Glick JM; Rader DJ
J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of the apolipoprotein-E and -E-complexes in lipoproteins of human serum with the apolipoprotein-E4/E3 phenotype].
Hidaka H; Tozuka M; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
Rinsho Byori; 1997 Dec; 45(12):1172-6. PubMed ID: 9437899
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein E phenotype has a strong influence on tracking of serum cholesterol and lipoprotein levels in children: a follow-up study from birth to the age of 11 years.
Kallio MJ; Salmenperä L; Siimes MA; Perheentupa J; Gylling H; Miettinen TA
Pediatr Res; 1998 Mar; 43(3):381-5. PubMed ID: 9505278
[TBL] [Abstract][Full Text] [Related]
20. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
Kissebah AH; Alfarsi S; Evans DJ; Adams PW
Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
